Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
GlobeNewswire, Inc.
Primary endpoint met: 83% attack rate reduction versus placebo (p<0.0001) in the first and only prophylaxis Phase 3 study in all three types of HAE 87% attack rate reduction versus placebo observed in people with HAE Type 1 or Type 2 All secondary...
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
GlobeNewswire, Inc.
MILAN and MORRISTOWN, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”, or the “Company”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases...
AMERICAN SWISS FOUNDATION HOSTS 2026 LEADERSHIP SUMMIT IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
"U.S.–Swiss Leadership in Technological Advancements” RÜSCHLIKON, ZÜRICH, SWITZERLAND, June 26, 2026 /EINPresswire.com/ -- On June 16–17, 2026, the American Swiss Foundation convened its annual Leadership Summit at the Swiss Re Centre for Global...
Secro Appoints Guy de Pourtalès As Chief Technology Officer
EIN Presswire
Strengthening SECRO’s bank-grade digital infrastructure, scalability, and AI roadmap for global trade finance documentation GENEVA, SWITZERLAND, July 1, 2026 /EINPresswire.com/ -- SECRO, the trade finance tokenization and document workflow...
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
GlobeNewswire, Inc.
PRESS RELEASE AB SCIENCE REPORTS COMPLETION OF THE STEP 3 OF PHASE 1, EVALUATING THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 WITH VENETOCLAX GENERATED A 67%...
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – June 24, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced that the Company has moved into additional laboratory space at its existing R&D site in...
Apex Red FUGA DU 2 celebrates 10th SwissPeaks Trail with Kailas FUGA
GlobeNewswire, Inc.
SION, Switzerland, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The world’s ultimate glacier-to-lake challenge, SwissPeaks Trail with Kailas FUGA, is celebrating its 10th anniversary with a limited-edition Apex Red FUGA DU 2. Recognised in 2025 by the...
Beauty&Longevity CHOICE Awards 2027 Open for Entries, Putting Science-Led Beauty & Longevity Innovation in the Spotlight
EIN Presswire
19 categories across four pillars—from skin longevity and metabolic health to diagnostics, devices and biotech.
Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study
GlobeNewswire, Inc.
PHocus met its primary endpoint, demonstrating a clinically meaningful and statistically significant placebo-adjusted reduction in pulmonary vascular resistance (PVR) of -56.3% (p<0.0001) at Week 16, the highest ever reported PVR reduction in any...
Natural Embrace™ Introduces Made in USA High-Tech Skincare for Sensitive Skin
EIN Presswire
LOS ANGELES, CA, UNITED STATES, June 30, 2026 /EINPresswire.com/ -- Natural Embrace™, a USA-based skincare company focused on advanced skin science and natural ingredients, is pleased to announce the introduction of its Made in USA skincare and...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient...
Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1
GlobeNewswire, Inc.
U.S. Food and Drug Administration accepted the New Drug Application with Priority Review for tinlarebant for the treatment of Stargardt disease type 1; Prescription Drug User Fee Act target action date of February 12, 2027 If approved, tinlarebant...
Parametric Insurance Market to Reach $34.4 Billion Globally by 2033, Growing at 6.6% CAGR | Allied Market Research
EIN Presswire
Rising Climate Risks, Rapid Claims Processing, AI-Driven Risk Modeling, and Expanding Alternative Risk Transfer Solutions Accelerate Global Market Growth WILMINGTON, DE, UNITED STATES, July 1, 2026 /EINPresswire.com/ -- According to a new report...
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
GlobeNewswire, Inc.
Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials.
Microshare®, Taqt and Zurich Airport announce digital transformation partnership for global airport terminal operations
EIN Presswire
Microshare has launched a partnership with Zurich Airport and device maker Taqt to expand globally its model of integrated, data-driven terminal operations.
Swiss Water Reports Voting Results from Annual General and Special Meeting of Shareholders
GlobeNewswire, Inc.
VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- Swiss Water Decaffeinated Coffee Inc. (TSX : SWP) (“Swiss Water” or “the Company”), a leading specialty coffee company and premium green coffee decaffeinator, is pleased to announce the...
Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call
GlobeNewswire, Inc.
BASEL, Switzerland and LONDON and NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Pulmovant today announced that results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with...
SEALSQ To Present at Maxim Group Defense Tech and Domestic Supply Chain Virtual Conference, on June 25
GlobeNewswire, Inc.
Geneva, Switzerland, June 23, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today...
Forward Edge-AI, Inc. and Forward Edge-AI, India Private Limited Unveil Vision for U.S.-India Deep Technology Alliance
EIN Presswire
A Strategic Partnership Advancing Deep-Tech in India SAN ANTONIO, TX, UNITED STATES, June 25, 2026 /EINPresswire.com/ -- Forward Edge-AI, Inc. and Forward Edge-AI India Private Limited today unveiled a shared vision for a next-generation...
Dragonfly Energy Appoints AI and Battery Technology Innovator Dr. Lukas Lutz to Board of Directors
GlobeNewswire, Inc.
RENO, Nev., June 23, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, today announced the appointment of Dr....
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.